Complete Conference Management 31st Annual San Diego Heart Failure Summer Symposium 2025

To keep pace with the rapid growth in our understanding of heart failure and, most importantly, to better treat patients with this disease, the 31st Annual San Diego Summer Heart Failure Symposium will provide a comprehensive overview of emerging concepts of heart failure management and new approaches to therapy. The series of didactic presentations, case discussions and Q & A sessions are designed to efficiently deliver new information that will help provide better care to patients and offer expert advice of how to implement new advances into clinical practice.
This year’s Symposium will present sessions on The Cardiorenal Liver Metabolic Axis, Advances in Treating HFpEF, PAH and Amyloidosis, Hypertrophic Cardiomyopathy, Managing Patients with Heart Failure, Atrial Fibrillation/Preventing Sudden Cardiac Death/Genetics and Gene Therapy and Catheter Based Interventions, Shock and Management of Advanced Heart Failure. The lectures in these sessions will provide a comprehensive overview of new drugs, devices and strategies for treating patients with heart failure and will describe practical approaches for implementation.
Highlights of the Symposium will be the 11th Annual Stanley Lloyd, M.D. Lecture on “Improving the Quality of Care and Outcomes for Heart Failure”, 2nd Annual Founders Lecture on “Heart Failure – Looking Back and Looking Forward: A 100 year Perspective” and Featured Talks on The Cardiometabolic-Kidney-Liver and What’s New in Cardiac Transplant. Each morning, the Symposium will start with a series of illustrative case vignettes, each one highlighting a different management strategy.
For this year’s Symposium I have recruited a world-renowned faculty representing multiple disciplines as well as patient advocates who will provide an important perspective on the goals of therapy. As in the past, the Symposium will be presented in hybrid format. We encourage providers to attend the live presentations at the beautiful Hilton La Jolla Torrey Pines where they can interact with their colleagues, speakers and industry representatives over the two-day Symposium. For those who can’t attend, on-line streaming of all sessions will be available. In addition, the Symposium will be available on-line for several weeks so that you will be able to return to lectures of interest or catch up on those that you missed.
SYMPOSIUM OBJECTIVES
At the conclusion of this program, the participant should be able to:

Summarize current and emerging treatments available for preventing and treating heart failure and provide information to help in the selection of the most effective choices in individual patients.
Review strategiesfor implementing medical and device therapiesthat will lead to improved outcomes in heart failure patients.
Define how specific populations including minorities, women and the elderly respond to various approaches to treating risk factors and heart failure

TARGET AUDIENCE
The target audience for this activity includes cardiologists, internists, primary care physicians, nurses and allied healthcare professionals.
 
+ Topics:

Friday, June 27, 2025 Pacific Time

7:00am Registration/Coffee/Visit Exhibits
7:30-8:10 Coffee and Case Vignettes Drs. Greenberg, Bhatia, Narezkina and Wilkinson
8:20-9:20 PRODUCT THEATRE I – Breakfast Session – Non-CME A Near-Complete TTR Stabilizer Intentionally Designed for Patients With ATTR-CM Speaker: Marcus Anthony (Tony) Urey, MD Sponsored by: BridgeBio
9:20 Visit Exhibits
9:30 Welcome and Introduction to the 31st Annual San Diego Summer Heart Failure Symposium Barry Greenberg, MD
SESSION I – The Cardiorenal Liver Metabolic Axis Pam Taub, MD (Moderator)
9:40-10:00 FEATURED LECTURE I The Cardiometabolic-Kidney-Liver Syndrome Pam Taub, MD, FACC
10:00-10:20 GLP-1 Agonists for Treating Obesity and CV Disease Harpreet Bhatia, MD
10:20-10:40 Novel Approaches for Optimizing Therapy of Dyslipidemia to Reduce CV Risk Michael Wilkinson, MD
10:40-11:00 Reducing the Risk of Cardiovascular-Kidney Disease with Finerenone Barry Greenberg, MD
11:00-11:20 Cardiometabolic Disease in Transplant Patients Antoinette Birs, MD
11:20-11:40 Identifying and Treating Chemotherapy Induced Cardiac Disease Anya Narezkina, MD
11:40-12:00 Update on Treating Patients with Aortic Stenosis Gary Ma, MD
12:00-12:20 Audience Q/A Pam Taub, MD (Moderator) Drs. Bhatia, Wilkinson, Greenberg, Birs, Narezkina, Ma and Andrew Willeford, PharmD (Panelists)
12:20 Visit Exhibits
12:30-1:30 PRODUCT THEATRE II – Lunch Session – Non-CME Introduction to AMVUTTRA® (vutrisiran) Rola Khedraki, MD Supported by: Alnylam
1:30 Visit Exhibits
Session II – Advances in Treating HFpEF, PAH and Amyloidosis Marcus Anthony (Tony) Urey, MD (Moderator)
1:45-2:05 Advances in Managing Patients with HFpEF Hilary Shapiro, MD
2:05-2:25 Defining and Treatment Pulmonary Arterial Hypertension (PAH) in 2025: What’s the Best Approach? Nick H. Kim, MD
2:25-2:45 Diagnosing and Treating Amyloidosis: How Do the Experts Do It? Marcus Anthony (Tony) Urey, MD
2:45 Coffee Break/Visit Exhibits
Session III – Hypertrophic Cardiomyopathy Jorge Silva Enciso, MD (Moderator)
3:00-3:20 Imaging the Heart to Identify Patients with HCM and Define Risk of Future Events Albert Hsaio, MD
3:20-3:40 Myosin Inhibitors and Other Novel Approaches for Treating Hypertrophic Cardiomyopathy Jorge Silva Enciso, MD
3:40-4:00 Gene Therapy for HCM Barry Greenberg, MD
4:00-4:15 Patient Perspective HCM Patient – TBD
4:15-4:45 Case Presentation/Audience Participation Tony Urey (Moderator) Drs. Shapiro, Silva Enciso, Hsaio, Greenberg, TBD (Panelists)
4:45 Adjourn Day 1

Saturday, June 28

7:00am Registration Opens
7:30-8:10 Coffee and Case Vignettes Drs. Greenberg, Wettersten, Elkayam, Heywood
8:20-9:20 PRODUCT THEATRE III – Breakfast Session – Non-CME Rethinking Hyperkalemia Management in Patients on RAASi Therapy Speakers: Vicky Kuo, PharmD, BCTXP and Vladimir Yurukov, PharmD, BCPS, APh Sponsored by: AstraZeneca
9:30 Welcome and Introduction to the 31st Annual San Diego Summer Heart Failure Symposium – Day 2 Barry Greenberg, MD
Session IV – Managing Patients with Heart Failure Barry Greenberg, MD (Moderator)
9:40-10:10 11th Annual Stanley Lloyd, MD Lecture Improving the Quality of Care and Outcomes for Heart Failure Gregg Fonarow, MD
10:10-10:30 Managing Social Determinants That Predispose Patients to Heart Failure Cheryl Anderson, PhD
10:30-10:45 Selecting Additional Guideline Recommended Therapies That Improve Outcomes Uri Elkayam, MD
10:45-11:00 Remote Monitoring Using Wearable and Implantable Devices J Thomas Heywood, MD, FACC
11:00-11:15 New Diuretic Options for Managing Volume Overload Nicholas Wettersten, MD
11:15-11:30 Cardiac Contractility Modulation Farshad Raissi, MD
11:30-11:45 Living with Heart Failure: A Patient’s Perspective Rhonda Monroe
11:45-12:10 Case Presentation and Panel Discussion with Audience Participation Antoinette Birs, MD (Presenter) Drs Fonarow, Anderson, Heywood, Elkayam, Wettersten, Raissi and Rhonda Monroe (Panelists)
12:10 Visit Exhibits
12:20-1:20 PRODUCT THEATRE IV – Lunch Session – Non-CME hATTR Progression: Addressing Polyneuropathy Rajeev Mohan, MD Supported by: AstraZeneca
1:20-1:45 FOUNDERS LECTURE Heart Failure – Looking Back and Looking Forward: A 100 year Perspective Clyde Yancy, MD
Session V – Atrial Fibrillation/Preventing Sudden Cardiac Death/Genetics and Gene Therapy Kimberly Hong, MD (Moderator)
1:45-2:00 Atrial Fibrillation: Rhythm vs Rate Control? Anticoagulation vs LAA Occlusion? Jonathan Hsu, MD
2:00-2:15 Preventing Sudden Cardiac Death; Role of Wearable Devices and New ICDs Fred Han, MD
2:15-2:30 Evaluating and Counseling Patients (and Their Families) with Suspected Genetic Cardiomyopathy Kimberly Hong, MD
2:30-2:45 Advances in Gene Therapy for Patients with Cardiomyopathy Barry Greenberg, MD
2:45-2:55 Gene Therapy – A Patients’s Perspective Deborah Hoffmann and Barry Greenberg, MD
2:55 Coffee Break/Visit Exhibits
Session VI – Catheter Based Interventions, Shock and Management of Advanced Heart Failure Hao (Howie) Tran, MD (Moderator)
3:10-3:25 Catheter Based Interventions for Mitral and Tricuspid Valve Disease Ryan Reeves, MD
3:25-3:40 Recognition and Treatment of Cardiogenic Shock Hao (Howie) Tran, MD
3:40-3:55 Use of Percutaneous Support Devices to Treat Patients with Shock Rola Khedraki, MD
3:55-4:10 FEATURED LECTURE II What’s New in Cardiac Transplant Marcus Anthony (Tony) Urey, MD
4:10-4:25 Improving Outcomes with LVADs Mark Kearns, MD
4:25-4:40 Heart Transplant: A Patient Perspective Speaker TBD
4:40-5:00 Panel Discussion Dr Howie Tran (Moderator) Drs. Yancy, Hong, Greenberg, Urey, Khedraki, Kearns, Meghan Philbrick PA, Jade Kozach PharmD (Panelists)